Jaydev Thakkar was named chief operating officer and Milan Shah was appointed chief technology officer of Biofourmis. Each executive left leadership positions at established, successful companies to join Biofourmis. Most recently, Thakkar was director of Digital Health and Innovation at pharmaceutical company Amgen Inc. Shah was most recently co-founder and CTO at Uptycs Inc. Biofourmis is a fast-growing global leader in digital therapeutics that powers personally predictive care.
George Grofik has been appointed senior VP, head of investor relations and communications, at Royalty Pharma. He joins Royalty Pharma from Sanofi, where he served as VP, head of global investor relations. Royalty Pharma is the industry leader in acquiring pharmaceutical royalties.
Joe Medel was hired as senior VP of Strategy for BW Health Group in an expansion of the company’s life science consulting division, BW Consulting. He joins BW Consulting with more than 25 years of marketing and consulting experience for companies such as bioStrategies Group, Capgemini and IQVIA. BW Consulting helps life science companies solve problems and address changing business needs in innovative ways. BW Health Group is dedicated to advancing the commercial goals of life science clients.
Robert Gebhardt has been made a managing director of PharmaVentures. He was at STJ Advisors (Capital Markets/IPO Advisory) and Goetz Partners (M&A) in London. PharmaVentures is a transaction advisory company and a world leader in partnering, pharma M&A deals, and strategic alliances.
Samantha Daugherty has been named VP, director of operations, at Clinical SCORE. Dougherty was VP of strategic resource management at SSRS Research. Clinical SCORE is a consulting and market research company for the biopharmaceutical industry.
Jay Stella has become chief business officer and Dr. Mark Bittinger was made VP and global head of biology at Sai Life Sciences. Stella held positions of increasing responsibility at Millennium Pharmaceuticals and Takeda Pharmaceuticals for 15 years, across strategy and operations, business development, and integrations and divestitures. Dr. Bittinger has had a stellar track record in research, innovation, and cross-functional leadership in organizations such as Merck Research Labs, Dana-Farber Cancer Institute, Agios Pharmaceuticals, and Novartis Institute of BioMedical Research. Sai Life Sciences is a full-service contract development and management organization.
Sally Langa has been appointed head of U.S. sales at Nanoform. Langa was VP, global business development, Development and Analytical Services for Catalent Pharma Solutions. Nanoform is an innovative nanoparticle medicine enabling company.